Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dexmedetomidine for Refractory Pain in Palliative Cancer Patients
Sponsor: St. Olavs Hospital
Summary
The goal of this study is to find out whether the medication dexmedetomidine can be a safe and effective additional treatment for cancer patients whose pain is not well controlled by standard pain medicines (such as opioids). The study includes 30 palliative care patients who still have significant pain despite standard pain treatment. All participants will receive dexmedetomidine, and outcomes related to efficacy and safety will be systematically observed.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2026-04-10
Completion Date
2027-12
Last Updated
2026-10-21
Healthy Volunteers
No
Locations (4)
Drammen Hospital
Drammen, Norway
Oslo University Hospital
Oslo, Norway
Univsersity Hospital of North Norway
Tromsø, Norway
St.Olavs Hospital, Trondheim Univsersity Hospital
Trondheim, Norway